褐色細胞腫
ポジトロン断層撮像法（PET）は腫瘍の増殖性や交感神経機能活性を評価することが可能な生理的な画像診断法である。近年ではコンピューター断層撮像装置（CT）が組み込まれた撮像装置となり，形態・機能を同時に評価することが可能である。褐色細胞腫へのPET/CTの適応は術前に転移病変の有無を評価することおよび転移病変が存在する悪性褐色細胞腫の治療指針の選択である。特に悪性褐色細胞腫の病型は多彩であり，最適な治療法の選択には情報量の多いPET/CT検査は有用である。...
Saved in:
| Published in | 日本内分泌・甲状腺外科学会雑誌 Vol. 32; no. 2; pp. 116 - 120 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
日本内分泌外科学会・日本甲状腺外科学会
2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2186-9545 |
| DOI | 10.11226/jaesjsts.32.2_116 |
Cover
| Abstract | ポジトロン断層撮像法（PET）は腫瘍の増殖性や交感神経機能活性を評価することが可能な生理的な画像診断法である。近年ではコンピューター断層撮像装置（CT）が組み込まれた撮像装置となり，形態・機能を同時に評価することが可能である。褐色細胞腫へのPET/CTの適応は術前に転移病変の有無を評価することおよび転移病変が存在する悪性褐色細胞腫の治療指針の選択である。特に悪性褐色細胞腫の病型は多彩であり，最適な治療法の選択には情報量の多いPET/CT検査は有用である。 |
|---|---|
| AbstractList | ポジトロン断層撮像法（PET）は腫瘍の増殖性や交感神経機能活性を評価することが可能な生理的な画像診断法である。近年ではコンピューター断層撮像装置（CT）が組み込まれた撮像装置となり，形態・機能を同時に評価することが可能である。褐色細胞腫へのPET/CTの適応は術前に転移病変の有無を評価することおよび転移病変が存在する悪性褐色細胞腫の治療指針の選択である。特に悪性褐色細胞腫の病型は多彩であり，最適な治療法の選択には情報量の多いPET/CT検査は有用である。 |
| Author | 真鍋, 治 玉木, 長良 吉永, 恵一郎 |
| Author_xml | – sequence: 1 fullname: 吉永, 恵一郎 organization: 独立行政法人放射線医学総合研究所分子イメージング研究センター – sequence: 1 fullname: 玉木, 長良 organization: 北海道大学大学院医学研究科核医学分野 – sequence: 1 fullname: 真鍋, 治 organization: 北海道大学大学院医学研究科核医学分野 |
| BookMark | eNo9TztOAzEUdBEkQhLRc4dd_N6z13YJET8pEk16663tQFYhoHUaakRBxwmo6GgQ4k7sMVgUoJkZaUajmT0xWN-ukxAHIEsAxOqw4ZSbvMklYYkeoBqIIYKtCqeV3hWTnBspJSE5tHYo9rvX5-7p4-vzvXt46R7fxmJnwaucJr88EvPTk_n0vJhdnl1Mj2ZFg0S6MBwRUTkVmNguooMEaJ0mI3WsVTCSpAKrwEkTuZYmuBglVHUvbB1oJI63tf1Uvkr-rl3ecHvvud0swyr5vxee0OMP9Ef-zXDNbZ-gb7BLTBI |
| ContentType | Journal Article |
| Copyright | 2015 日本内分泌外科学会・日本甲状腺外科学会 |
| Copyright_xml | – notice: 2015 日本内分泌外科学会・日本甲状腺外科学会 |
| DOI | 10.11226/jaesjsts.32.2_116 |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| EndPage | 120 |
| ExternalDocumentID | article_jaesjsts_32_2_32_116_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 RJT |
| ID | FETCH-LOGICAL-j2335-7ad222494ca3a8fd91e128953705db4c703041841907dab07c9dd016b7c98bc3 |
| ISSN | 2186-9545 |
| IngestDate | Wed Sep 03 06:30:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| License | https://creativecommons.org/licenses/by-nc/4.0/deed.ja |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2335-7ad222494ca3a8fd91e128953705db4c703041841907dab07c9dd016b7c98bc3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jaesjsts/32/2/32_116/_article/-char/ja |
| PageCount | 5 |
| ParticipantIDs | jstage_primary_article_jaesjsts_32_2_32_116_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2015 |
| PublicationDateYYYYMMDD | 2015-01-01 |
| PublicationDate_xml | – year: 2015 text: 2015 |
| PublicationDecade | 2010 |
| PublicationTitle | 日本内分泌・甲状腺外科学会雑誌 |
| PublicationTitleAlternate | 内分泌甲状腺外会誌 |
| PublicationYear | 2015 |
| Publisher | 日本内分泌外科学会・日本甲状腺外科学会 |
| Publisher_xml | – name: 日本内分泌外科学会・日本甲状腺外科学会 |
| References | 20. Adler JT, Meyer-Rochow GY, Chen H, et al.: Pheochromocytoma: current approaches and future directions. Oncologist 13: 779-793, 2008 2. deKemp RA, Yoshinaga K, Beanlands RS: Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 14: 380-397, 2007 19. Timmers HJ, Chen CC, Carrasquillo JA, et al.: Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 104: 700-708, 2012 14. Rufini V, Treglia G, Castaldi P, et al.: Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging 57: 122-133, 2013 6. Timmers HJ, Taieb D, Pacak K: Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Horm Metab Res 44: 367-372, 2012 11. Yamamoto S, Hellman P, Wassberg C, et al.: 11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma:a single center experience over 11 years. J Clin Endocrinol Metab 97: 2423-2432, 2012 25. van Hulsteijn LT, Niemeijer ND, Dekkers OM, et al.: (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf) 80: 487-501, 2014 5. Havekes B, Lai EW, Corssmit EP, et al.: Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52: 419-429, 2008 15. Carrasquillo JA, Chen CC: Molecular imaging of neuroendocrine tumors. Semin Oncol 37: 662-679, 2010 22. Giammarile F, Chiti A, Lassmann M, et al.: EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging 35: 1039-1047, 2008 10. Yoshinaga K, Tomiyama Y, Manabe O, et al.: Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT. Ann Nucl Med 28: 761-769, 2014 26. Yoshinaga K, Oriuchi N, Wakabayashi H, et al.: Effects and safety of (131)I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors:Results from a multicenter observational registry. Endocr J 61: 1171-1180, 2014 18. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al.: Lymph node staging in non-small-cell lung cancer with FDG-PET scan:a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16: 2142-2149, 1998 24. Wahl RL, Jacene H, Kasamon Y, et al.: From RECIST to PERCIST:Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl1): 122S-150S, 2009 17. Li Y, Schiepers C, Lake R, et al.: Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone 50: 128-139, 2012 23. Lehnert H, Mundschenk J, Hahn K: Malignant pheochromocytoma. Front Horm Res 31: 155-162, 2004 13. Ilias I, Yu J, Carrasquillo JA, et al.: Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88: 4083-4087, 2003 12. Lautamaki R, Tipre D, Bengel FM: Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging 34(Suppl1): S74-85, 2007 7. Taieb D, Timmers HJ, Hindie E, et al.: EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39: 1977-1995, 2012 1. Yoshinaga K, Chow BJ, dekemp RA, et al.: Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 11: 903-932, 2005 9. Trampal C, Engler H, Juhlin C, et al.: Pheochromocytomas:detection with 11C hydroxyephedrine PET. Radiology 230: 423-428, 2004 8. Juweid ME, Cheson BD: Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354: 496-507, 2006 21. Gonias S, Goldsby R, Matthay KK, et al.: Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol 27: 4162-4168, 2009 27. Menzel C, Graichen S, Berner U, et al.: Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET. Acta Med Austriaca 30: 37-40, 2003 4. Lenders JW, Eisenhofer G, Mannelli M, et al.: Phaeochromocytoma. Lancet 366: 665-675, 2005 16. Maurice JB, Troke R, Win Z, et al.: A comparison of the performance of (6)(8)Ga-DOTATATE PET/CT and (1)(2)(3)I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39: 1266-1270, 2012 3. Takayanagi R, Miura K, Nakagawa H, et al.: Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother 54(Suppl1): 164s-168s, 2000 |
| References_xml | – reference: 7. Taieb D, Timmers HJ, Hindie E, et al.: EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39: 1977-1995, 2012 – reference: 6. Timmers HJ, Taieb D, Pacak K: Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Horm Metab Res 44: 367-372, 2012 – reference: 22. Giammarile F, Chiti A, Lassmann M, et al.: EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging 35: 1039-1047, 2008 – reference: 24. Wahl RL, Jacene H, Kasamon Y, et al.: From RECIST to PERCIST:Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl1): 122S-150S, 2009 – reference: 27. Menzel C, Graichen S, Berner U, et al.: Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET. Acta Med Austriaca 30: 37-40, 2003 – reference: 11. Yamamoto S, Hellman P, Wassberg C, et al.: 11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma:a single center experience over 11 years. J Clin Endocrinol Metab 97: 2423-2432, 2012 – reference: 18. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al.: Lymph node staging in non-small-cell lung cancer with FDG-PET scan:a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16: 2142-2149, 1998 – reference: 21. Gonias S, Goldsby R, Matthay KK, et al.: Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol 27: 4162-4168, 2009 – reference: 15. Carrasquillo JA, Chen CC: Molecular imaging of neuroendocrine tumors. Semin Oncol 37: 662-679, 2010 – reference: 26. Yoshinaga K, Oriuchi N, Wakabayashi H, et al.: Effects and safety of (131)I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors:Results from a multicenter observational registry. Endocr J 61: 1171-1180, 2014 – reference: 20. Adler JT, Meyer-Rochow GY, Chen H, et al.: Pheochromocytoma: current approaches and future directions. Oncologist 13: 779-793, 2008 – reference: 17. Li Y, Schiepers C, Lake R, et al.: Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone 50: 128-139, 2012 – reference: 1. Yoshinaga K, Chow BJ, dekemp RA, et al.: Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 11: 903-932, 2005 – reference: 9. Trampal C, Engler H, Juhlin C, et al.: Pheochromocytomas:detection with 11C hydroxyephedrine PET. Radiology 230: 423-428, 2004 – reference: 14. Rufini V, Treglia G, Castaldi P, et al.: Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging 57: 122-133, 2013 – reference: 4. Lenders JW, Eisenhofer G, Mannelli M, et al.: Phaeochromocytoma. Lancet 366: 665-675, 2005 – reference: 12. Lautamaki R, Tipre D, Bengel FM: Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging 34(Suppl1): S74-85, 2007 – reference: 3. Takayanagi R, Miura K, Nakagawa H, et al.: Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother 54(Suppl1): 164s-168s, 2000 – reference: 19. Timmers HJ, Chen CC, Carrasquillo JA, et al.: Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 104: 700-708, 2012 – reference: 23. Lehnert H, Mundschenk J, Hahn K: Malignant pheochromocytoma. Front Horm Res 31: 155-162, 2004 – reference: 2. deKemp RA, Yoshinaga K, Beanlands RS: Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 14: 380-397, 2007 – reference: 25. van Hulsteijn LT, Niemeijer ND, Dekkers OM, et al.: (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf) 80: 487-501, 2014 – reference: 13. Ilias I, Yu J, Carrasquillo JA, et al.: Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88: 4083-4087, 2003 – reference: 16. Maurice JB, Troke R, Win Z, et al.: A comparison of the performance of (6)(8)Ga-DOTATATE PET/CT and (1)(2)(3)I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39: 1266-1270, 2012 – reference: 5. Havekes B, Lai EW, Corssmit EP, et al.: Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52: 419-429, 2008 – reference: 8. Juweid ME, Cheson BD: Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354: 496-507, 2006 – reference: 10. Yoshinaga K, Tomiyama Y, Manabe O, et al.: Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT. Ann Nucl Med 28: 761-769, 2014 |
| SSID | ssj0003239288 ssib012362452 |
| Score | 2.0045114 |
| Snippet | ポジトロン断層撮像法（PET）は腫瘍の増殖性や交感神経機能活性を評価することが可能な生理的な画像診断法である。近年ではコンピューター断層撮像装置（CT）が組み... |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 116 |
| SubjectTerms | アイソトープ治療 ポジトロン断層撮像検査 褐色細胞腫 転移 |
| Title | 褐色細胞腫 |
| URI | https://www.jstage.jst.go.jp/article/jaesjsts/32/2/32_116/_article/-char/ja |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 日本内分泌・甲状腺外科学会雑誌, 2015, Vol.32(2), pp.116-120 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library issn: 2186-9545 databaseCode: KQ8 dateStart: 20120101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html omitProxy: true ssIdentifier: ssj0003239288 providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR27jtQw0Lo7GpoTCBBvXcGUWTZ-xRaVvZfVCQkkpEO6LkripNjiQOxecy2ioKOipKKjQYh_Yj-DGSebXXRX3HKNNbFnxuOZrD2Z9diMPZNBZbZsyyTVgUI3tUrKTKVJzWWcMLmuKMH51Wt99Fa-PFEnO7tfN3YtnS2qUX1-aV7J_1gV69CulCW7hWUHpliBMNoXS7QwlleyMeQGnAQ7JsBY8BzyDLwE39UIsHkEFDi_6YZCrsFm4FQEJuAmkCswmjAJMARjkxdgsEkQK--JuZV9L8aB1z1z74iKJNHU5BAtjTWH4LAGSSZgEceC9bEJxXbIeWVtwsVB4AiozzF4Q5anB5OCV5GDoT0ZyAElMfmaEAXJe0IaR0-IHaFUWa8WN93ERzQ7jZwOwfhVRzgo7zdDIF36Z3xdt9TWVTQxaPQi52vpeD2v0y1giVXdKZqrRWgd5B1iAd2KkqZ6wzlJY-bgJesej1d1zspmPpsv5iPBR7wYSP85T7x_W4sVbiF4walA9GLVSCl_iLHLbnCKc9FmhzfDPE0H9tAf9kMsU3D0suMVr8PYhvw0rp9fkAq9PXwe9k1GV-74Ftvvv8EOXCfFbbYzK--w_eX3L8vPv_78_rn8-G356cdddjzNjydHSX9bSDLjgs5dLQP6utLKuhSlaYNNG_S9rBLZWIVK1rS0ydRI9ICzUFbjrLYh4AdPhYCpanGP7Z2-O23uswNbtdqacVCNbCUP2qraqrbKpBWhyUT7gL3oxC_edyfCFNvo9OG1qB-xm_QL6IKAj9ne4sNZ8wTd4kX1NNroL3I2gXQ |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%A4%90%E8%89%B2%E7%B4%B0%E8%83%9E%E8%85%AB&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E5%88%86%E6%B3%8C%E3%83%BB%E7%94%B2%E7%8A%B6%E8%85%BA%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%90%89%E6%B0%B8%2C+%E6%81%B5%E4%B8%80%E9%83%8E&rft.au=%E7%8E%89%E6%9C%A8%2C+%E9%95%B7%E8%89%AF&rft.au=%E7%9C%9F%E9%8D%8B%2C+%E6%B2%BB&rft.date=2015&rft.pub=%E6%97%A5%E6%9C%AC%E5%86%85%E5%88%86%E6%B3%8C%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A%E3%83%BB%E6%97%A5%E6%9C%AC%E7%94%B2%E7%8A%B6%E8%85%BA%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=2186-9545&rft.volume=32&rft.issue=2&rft.spage=116&rft.epage=120&rft_id=info:doi/10.11226%2Fjaesjsts.32.2_116&rft.externalDocID=article_jaesjsts_32_2_32_116_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2186-9545&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2186-9545&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2186-9545&client=summon |